Page last updated: 2024-08-21

arsenic trioxide and Nervous System Disorders

arsenic trioxide has been researched along with Nervous System Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Warrell, RP1
Calleja, E; Coutré, S; Dahlberg, S; Douer, D; Ellison, R; Frankel, SR; Kalaycio, M; Kantarjian, H; Scheinberg, DA; Sievers, EL; Soignet, SL; Steinherz, P; Stone, RM; Tallman, MS; Warrell, RP1

Reviews

1 review(s) available for arsenic trioxide and Nervous System Disorders

ArticleYear
Arsenicals and inhibitors of histone deacetylase as anticancer therapy.
    Haematologica, 1999, Volume: 84 Suppl EHA-4

    Topics: Acetylation; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Child; China; Chromatin; Drug Evaluation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gastrointestinal Diseases; Histone Deacetylase Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Melarsoprol; Neoplasm Proteins; Neoplasms; Nervous System Diseases; Oxides; Phenylbutyrates; Protein Processing, Post-Translational; Salvage Therapy; Tretinoin

1999

Trials

1 trial(s) available for arsenic trioxide and Nervous System Disorders

ArticleYear
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Sep-15, Volume: 19, Issue:18

    Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Electrocardiography; Female; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Middle Aged; Nervous System Diseases; Oxides; Pilot Projects; Platelet Count; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Syndrome

2001